Long--Term Free Survival of Two Class III β-Thalassemic Patients after Non-Myeloablative Stem Cell Transplantation

At present, hematopoietic stem cell transplantation is the only curative treatment for β thalassemia patients. Conventional myeloablative stem cell transplantation is associated with significant morbidity and mortality, and non-myeloablative stem cell transplantation is associated with high graft fa...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Hematol Oncol Stem Cell Res
Auteurs principaux: Adib Sereshki, Mohammad Mahdi, Bahar, Babak, Ghavamzadeh, Ardeshir, Mousavi, Seyed Asadollah, Alimoghaddam, Kamran
Format: Artigo
Langue:Inglês
Publié: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2020
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7231797/
https://ncbi.nlm.nih.gov/pubmed/32461795
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires